Latest Breaking News On - Interleukins global market report - Page 3 : comparemela.com
Share this article
Share this article
ResearchAndMarkets.com s offering.
Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.
Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical.
The global interleukins market is expected to grow from $0.83 billion in 2019 to $1.6 billion in 2020 at a compound annual growth rate (CAGR) of 93.0%. The slow growth despite being launched in 2019 is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The mark
United-states
Dublin
Ireland
France
America
Laura-wood
E-st-office-hours-call
Custom-research
Bio-thera-solutions
Synthorx-inc
Office-hours-call
Research-institutes
ResearchAndMarkets.com’s offering.
Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.
Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical.
The global interleukins market is expected to grow from $0.83 billion in 2019 to $1.6 billion in 2020 at a compound annual growth rate (CAGR) of 93.0%. The slow growth despite being launched in 2019 is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach
United-states
France
America
Laura-wood
E-st-office-hours-call
Bio-thera-solutions
Synthorx-inc
Office-hours-call
Research-institutes
Gedeon-richter
Interleukins-global-market-report
Sunshine-guojian
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Biosimilar Interleukins Market Report 2020-2030: Long-term COVID-19 Growth and Change - ResearchAndMarkets.com
February 4, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 4, 2021
Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.
ADVERTISEMENT
Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical.
The global interleukins market is expected to grow from $0.83 billion in 2019 to $1.6 billion in 2020 at a compound annual growth rate (CAGR) of 93.0%. The slow growth despite being launched in 2019 is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social di
United-states
France
America
Laura-wood
E-st-office-hours-call
Bio-thera-solutions
Synthorx-inc
Office-hours-call
Research-institutes
Gedeon-richter
Interleukins-global-market-report
Sunshine-guojian
vimarsana © 2020. All Rights Reserved.